PMID- 17313444 OWN - NLM STAT- MEDLINE DCOM- 20070529 LR - 20220310 IS - 0019-2805 (Print) IS - 1365-2567 (Electronic) IS - 0019-2805 (Linking) VI - 121 IP - 1 DP - 2007 May TI - CTLA-4 regulates allergen response by modulating GATA-3 protein level per cell. PG - 62-70 AB - T helper type 2 (Th2) cell differentiation requires the expression of GATA-3, a transcription factor that allows transcriptional activation of Th2 cytokine genes through chromatin remodelling. We investigated the role of the negative costimulatory receptor cytotoxic T-lymphocyte antigen 4 (CTLA-4) in the regulation of GATA-3 expression, Th2 differentiation and immunoglobulin production during the immune response to allergens. BALB/c mice were immunized with a recombinant major allergenic component of Parietaria judaica pollen, rPar j I, and treated with blocking anti-CTLA-4 or control antibodies. Results showed that in vivo CTLA-4 blockade enhanced the Par j I-specific immunoglobulin E (IgE) serum level. In contrast, Par j I-specific IgG2a serum level was reduced, suggesting that CTLA-4 blockade skewed immunoglobulin production towards interleukin-4 (IL-4) -dependent immunoglobulin isotypes. Consistently, CTLA-4 blockade increased the frequency of Par j I-specific Th2 cells but not Th1 cells, as well as IL-4 and IL-5 but not interferon-gamma production. Our data also showed that CTLA-4 blockade enhanced the GATA-3 : T-bet messenger RNA ratio. Interestingly, in vivo CTLA-4 blockade did not increase the frequency of GATA-3 protein-expressing cells. In contrast, it enhances GATA-3 protein level per cell. Further, in vitro results show that the anti-CTLA-4 monoclonal antibody, by competing with CD80 for CTLA-4 binding, induced an enhancement in the frequency of IL-4-producing cells that correlates with the increase in GATA-3 protein level per cell. In conclusion, CTLA-4, by affecting the level of GATA-3 per cell, contributes to keeping this factor under the threshold required to become a Th2 effector cell. Consequently, it affects IgE/IgG2a production and contributes to the outcome of allergen-specific immune responses. FAU - Nasta, Francesca AU - Nasta F AD - ENEA, Unit of Biotechnology, Section of Toxicology and Biomedicine, Rome, Italy. FAU - Corinti, Silvia AU - Corinti S FAU - Bonura, Angela AU - Bonura A FAU - Colombo, Paolo AU - Colombo P FAU - Di Felice, Gabriella AU - Di Felice G FAU - Pioli, Claudio AU - Pioli C LA - eng PT - Journal Article DEP - 20070220 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Allergens) RN - 0 (Antibodies, Monoclonal) RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation) RN - 0 (CTLA-4 Antigen) RN - 0 (Ctla4 protein, mouse) RN - 0 (GATA3 Transcription Factor) RN - 0 (Gata3 protein, mouse) RN - 0 (Immunoglobulin G) RN - 0 (Par j I protein, Parietaria judaica) RN - 0 (Plant Proteins) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - 207137-56-2 (Interleukin-4) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Allergens/*immunology MH - Animals MH - Antibodies, Monoclonal/immunology MH - Antigens, CD/*immunology MH - Antigens, Differentiation/*immunology MH - CTLA-4 Antigen MH - Cell Differentiation/immunology MH - Cells, Cultured MH - Female MH - GATA3 Transcription Factor/genetics/*metabolism MH - Gene Expression Regulation/immunology MH - Immunoglobulin E/biosynthesis MH - Immunoglobulin G/biosynthesis MH - Interleukin-4/biosynthesis MH - Mice MH - Mice, Inbred BALB C MH - Plant Proteins/immunology MH - RNA, Messenger/genetics MH - Recombinant Proteins/immunology MH - Th2 Cells/immunology PMC - PMC2265929 EDAT- 2007/02/23 09:00 MHDA- 2007/05/30 09:00 PMCR- 2008/05/01 CRDT- 2007/02/23 09:00 PHST- 2007/02/23 09:00 [pubmed] PHST- 2007/05/30 09:00 [medline] PHST- 2007/02/23 09:00 [entrez] PHST- 2008/05/01 00:00 [pmc-release] AID - IMM2537 [pii] AID - 10.1111/j.1365-2567.2007.02537.x [doi] PST - ppublish SO - Immunology. 2007 May;121(1):62-70. doi: 10.1111/j.1365-2567.2007.02537.x. Epub 2007 Feb 20.